Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferinject for Postoperative Anemia in Cardiac Surgery
NCT02939794Phase 4Unknown
- Sponsor
- Rambam Health Care Campus
- Start
- Nov 2016
- Primary completion
- Aug 2018
01
Overview
Phase 4, randomised, double-blind trial of ferric carboxymaltose in anemia, sponsored by Rambam Health Care Campus. Primary endpoints: Number of red packed cells administered postoperation at 2 years and Hemoglobin concentration at 2 years. Status: unknown.
02
Drugs
ferric carboxymaltose
03
Conditions
anemia
Beyond the preview
Go deeper on NCT02939794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02939794.